AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8047518 — intervention group
Group type: COMPARATOR
Intervention: Control group not offered free immunizations
Number of subjects: 1989
Study 2522746 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural injection of 10 ml of autologous blood
Number of subjects: 100
Study 2522746 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (10 ml)
Number of subjects: 100
Study 6195761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime and Cefotaxim (antibiotic prophylaxis)
Number of subjects: 300
Study 6195761 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic prophylaxis (control group)
Number of subjects: 300
Study 31984873 — intervention group
Group type: EXPERIMENTAL
Intervention: Media literacy intervention with counter argument production
Number of subjects: 0
Study 31984873 — intervention group
Group type: EXPERIMENTAL
Intervention: Media literacy intervention with counter story production
Number of subjects: 0
Study 31984873 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 0
Study 30229999 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D deficiency (<10 ng/mL)
Number of subjects: 180
Study 30229999 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D sufficiency (>20 ng/mL)
Number of subjects: 180
Study 28512725 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibrate (50 mg/kg single dose prior to phototherapy)
Number of subjects: 90
Study 28512725 — intervention group
Group type: COMPARATOR
Intervention: Standard care (only phototherapy)
Number of subjects: 90
Study 26068230 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral activation for diabetic retinopathy prevention
Number of subjects: 206
Study 26068230 — intervention group
Group type: COMPARATOR
Intervention: Supportive therapy (control)
Number of subjects: 206
Study 24411083 — intervention group
Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg/d
Number of subjects: 917
Study 24411083 — intervention group
Group type: COMPARATOR
Intervention: Finasteride 1 mg/d
Number of subjects: 917
Study 24411083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 917
Study 21894450 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibration training at 20 Hz with an amplitude of 2-4 mm for 2 × 5 min/day
Number of subjects: 8
Study 21894450 — intervention group
Group type: COMPARATOR
Intervention: Control intervention without vibration
Number of subjects: 8
Study 20042867 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 days on sick leave wearing a neck collar
Number of subjects: 2
Study 20042867 — intervention group
Group type: EXPERIMENTAL
Intervention: Part-time sick leave and work adjustments
Number of subjects: 2
Study 20042867 — intervention group
Group type: COMPARATOR
Intervention: No neck collar or sick leave
Number of subjects: 2
Study 20042867 — intervention group
Group type: COMPARATOR
Intervention: Full-time sick leave
Number of subjects: 2
Study 17701375 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral pudendal nerve block with 0.25 percent bupivacaine
Number of subjects: 100
Study 17701375 — intervention group
Group type: COMPARATOR
Intervention: Routine technique in use in the Department of Anesthesia (Control)
Number of subjects: 100
Study 15839466 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised formulation of mefloquine (Mephaquin Lactabs/Test)
Number of subjects: 0
Study 15839466 — intervention group
Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 0
Study 12495804 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg buprenorphine
Number of subjects: 513
Study 12495804 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg buprenorphine
Number of subjects: 513
Study 12495804 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg buprenorphine
Number of subjects: 513
Study 9650332 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous mitral valvotomy (PMV) in Group I (20 patients)
Number of subjects: 27
Study 9650332 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous mitral valvotomy (PMV) in Group II (7 patients)
Number of subjects: 27
Study 9650332 — intervention group
Group type: COMPARATOR
Intervention: Follow-up after PMV in patients with previous MC
Number of subjects: 27
Study 8091360 — intervention group
Group type: COMPARATOR
Intervention: 40 mg per day of lisinopril
Number of subjects: 68
Study 8091360 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 20 mg of lisinopril and 12.5 mg of hydrochlorothiazide per day
Number of subjects: 68
Study 2535973 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen
Number of subjects: 21
Study 2535973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 73903 — intervention group
Group type: EXPERIMENTAL
Intervention: Effervescent activated charcoal (10 g packet containing 5 g activated charcoal) administered 30 min after 75 mg nortriptyline
Number of subjects: 0
Study 73903 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of effervescent activated charcoal
Number of subjects: 0
Study 31277053 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 at 1.2 pmol/kg/min
Number of subjects: 192
Study 31277053 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 192
Study 29062346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.5mg/kg
Number of subjects: 39
Study 29062346 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 39
Study 25810066 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN, 60 mg single dose, day 5) with cortisol (200 mg per day, days 1-6)
Number of subjects: 8
Study 25810066 — intervention group
Group type: COMPARATOR
Intervention: Cortisol (200 mg per day, days 1-6) with placebo (single dose, day 5)
Number of subjects: 8
Study 25810066 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (ISMN)
Number of subjects: 8
Study 24044618 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting calorie restriction (FCR) - reduction of 300-500 kcal/d combined with 2 days/week of Muslim Sunnah Fasting
Number of subjects: 0
Study 21670611 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal local anesthetic (IPLA) - ropivacaine 75 mg instillation before dissection and 0.2% solution at 4 mL/hour for 3 days postoperative infusion
Number of subjects: 60
Study 21670611 — intervention group
Group type: COMPARATOR
Intervention: Placebo - 0.9% saline solution instillation and infusion
Number of subjects: 60
Study 19553646 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine early PCI within 6 hours after fibrinolysis
Number of subjects: 1059
Study 19553646 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (including rescue PCI or delayed angiography)
Number of subjects: 1059
Study 19553646 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine early PCI
Number of subjects: 1059
Study 19553646 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 1059
Study 17394009 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 18 weeks (2 days/week)
Number of subjects: 23
Study 17394009 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Training (AER) for 18 weeks (2 days/week)
Number of subjects: 23
Study 17394009 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial artery flow mediated dilation (FMD)
Number of subjects: 23
Study 16113435 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid/beta(2)‐agonist combination therapy
Number of subjects: 0
Study 11201519 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 24
Study 11201519 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HRT)
Number of subjects: 24
Study 9881552 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg oral ciprofloxacin eight hours before surgery
Number of subjects: 46
Study 9881552 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 drops of 0.3% ciprofloxacin applied every twenty minutes starting 100 minutes before surgery
Number of subjects: 46
Study 7770137 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia (TIVA) with midazolam and alfentanil
Number of subjects: 40
Study 7770137 — intervention group
Group type: COMPARATOR
Intervention: Conventional inhalation anaesthesia
Number of subjects: 40
Study 2457006 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 cycles of ABVD chemotherapy
Number of subjects: 157
Study 2457006 — intervention group
Group type: COMPARATOR
Intervention: 2 cycles of MOPP + 2 cycles of ABVD chemotherapy
Number of subjects: 157
Study 2457006 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation at a low dose (20 Gy) for good responders
Number of subjects: 157
Study 2457006 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediastinal boost (up to 40 Gy) for poor responders
Number of subjects: 157
Study 2457006 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 157
Study 2457006 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-free survival rate
Number of subjects: 157
Study 31642426 — intervention group
Group type: EXPERIMENTAL
Intervention: Double filtration plasmapheresis (DFPP) combined with methylprednisolone (MP) and cyclophosphamide (CTX) pulse therapy
Number of subjects: 60
Study 31642426 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP) and cyclophosphamide (CTX) pulse therapy
Number of subjects: 60
Study 31642426 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 28639097 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week Internet-based tailored exercise program
Number of subjects: 0
Study 28639097 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 25032943 — intervention group
Group type: COMPARATOR
Intervention: 8% glucose hyperbaric SAS
Number of subjects: 120
Study 25032943 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.8% glucose hyperbaric SAS
Number of subjects: 120
Study 25032943 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% glucose hyperbaric SAS
Number of subjects: 120
Study 25032943 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.33% glucose hyperbaric SAS
Number of subjects: 120
Study 25032943 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 23766446 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored low-salt diet
Number of subjects: 56
Study 23766446 — intervention group
Group type: COMPARATOR
Intervention: Standard low-salt advice
Number of subjects: 56
Study 21373801 — intervention group
Group type: EXPERIMENTAL
Intervention: Large femoral head metal-on-metal (MM) total hip arthroplasty
Number of subjects: 50
Study 21373801 — intervention group
Group type: COMPARATOR
Intervention: 28-mm metal-on-polyethylene (MP) total hip arthroplasty
Number of subjects: 50
Study 21373801 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MM and MP)
Number of subjects: 50
Study 19233003 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5 mL of 3.5% lidocaine dissolved in fibrin glue (Group A)
Number of subjects: 30
Study 19233003 — intervention group
Group type: COMPARATOR
Intervention: 7.5 mL of lidocaine alone (Group B)
Number of subjects: 30
Study 19233003 — intervention group
Group type: COMPARATOR
Intervention: 7.5 mL of fibrin glue alone (Group C)
Number of subjects: 30
Study 16824157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1052
Study 12778099 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole mouth taste test and spatial taste test in postmenopausal women
Number of subjects: 20
Study 12778099 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective assessment of taste alteration in postmenopausal women
Number of subjects: 20
Study 12778099 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteration in dietary habits after menopause
Number of subjects: 20
Study 10933266 — intervention group
Group type: EXPERIMENTAL
Intervention: Familial cattle ownership
Number of subjects: 176
Study 10933266 — intervention group
Group type: EXPERIMENTAL
Intervention: Living more than 2 hours away from a water source
Number of subjects: 176
Study 10933266 — intervention group
Group type: EXPERIMENTAL
Intervention: Facial cleanliness at both time points
Number of subjects: 176
Study 10933266 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a clean face at both time points in non-cattle-herding families
Number of subjects: 176
Study 10933266 — intervention group
Group type: EXPERIMENTAL
Intervention: Living more than 2 hours away from a water source in cattle-herding families
Number of subjects: 176
Study 10933266 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe inflammatory trachoma at baseline
Number of subjects: 176
Study 9330125 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (up to 25 mg twice daily, n = 70)
Number of subjects: 131
Study 9330125 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 35)
Number of subjects: 131
Study 9330125 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 131
Study 9330125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 8399552 — intervention group
Group type: EXPERIMENTAL
Intervention: T‐set (new connector device for CAPD); 27‐cm extension line filled with Amuchina during dwell time.
Number of subjects: 122
Study 8399552 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) using a long branch or short branch Y‐set.
Number of subjects: 122
Study 3094957 — intervention group
Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 40
Study 3094957 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen with codeine
Number of subjects: 40
Study 29239515 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-discharge initiation of sacubitril/valsartan (initiated ≥24 hours after hemodynamic stabilization)
Number of subjects: 1000
Study 29239515 — intervention group
Group type: COMPARATOR
Intervention: Post-discharge initiation of sacubitril/valsartan (initiated within Days 1-14 after discharge)
Number of subjects: 1000
Study 27483525 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARLY (computer‐aided training platform with a biofeedback interface)
Number of subjects: 67
Study 27483525 — intervention group
Group type: EXPERIMENTAL
Intervention: CHARLY
Number of subjects: 67
Study 27483525 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine training)
Number of subjects: 67
Study 24961394 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet high in n-3 fatty acids and polyphenols
Number of subjects: 78
Study 24961394 — intervention group
Group type: COMPARATOR
Intervention: Other isoenergetic diets differing in n-3 FA and polyphenol content
Number of subjects: 78
Study 22207700 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated symbols
Number of subjects: 52
Study 22207700 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated verbs
Number of subjects: 52
Study 22207700 — intervention group
Group type: COMPARATOR
Intervention: Static verbs
Number of subjects: 52
Study 22207700 — intervention group
Group type: EXPERIMENTAL
Intervention: Animated prepositions
Number of subjects: 52
Study 22207700 — intervention group
Group type: COMPARATOR
Intervention: Static prepositions
Number of subjects: 52
Study 22207700 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbs
Number of subjects: 52
Study 22207700 — intervention group
Group type: COMPARATOR
Intervention: Prepositions
Number of subjects: 52
Study 22207700 — intervention group
Group type: EXPERIMENTAL
Intervention: Older children
Number of subjects: 52
Study 22207700 — intervention group
Group type: COMPARATOR
Intervention: Younger children
Number of subjects: 52
Study 21091415 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise program (3 months, starting at 16-20 weeks of gestation)
Number of subjects: 64
Study 21091415 — intervention group
Group type: COMPARATOR
Intervention: Usual activities (control group)
Number of subjects: 64
Study 19231908 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 1991
Study 19231908 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 1991
Study 19231908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1991
Study 16238893 — intervention group
Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 3
Study 16238893 — intervention group
Group type: COMPARATOR
Intervention: Conventional amphotericin B
Number of subjects: 3
Study 16238893 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole
Number of subjects: 3
Study 16238893 — intervention group
Group type: COMPARATOR
Intervention: Voriconazole vs Conventional amphotericin B
Number of subjects: 3
Study 16238893 — intervention group
Group type: COMPARATOR
Intervention: Voriconazole vs Itraconazole
Number of subjects: 3
Study 12885812 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 100 mg/m2 weekly for 3 of 4 weeks with carboplatin (AUC = 6)
Number of subjects: 401
Study 12885812 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 100 mg/m2 and carboplatin (AUC = 2) weekly for 3 of 4 weeks
Number of subjects: 401
Study 12885812 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel 150 mg/m2 cycle 1 and 100 mg/m2 cycle 2 and carboplatin (AUC = 2) weekly for 6 of 8 weeks
Number of subjects: 401
Study 12885812 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel therapy (70 mg/m2, 3 of 4 weeks)
Number of subjects: 401
Study 12885812 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 401
Study 10553410 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (CDDP 16 mg/m2 for 5 days, 5-FU 600 mg/m2/day for 120 hours)
Number of subjects: 27
Study 10553410 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen B (CDDP 80 mg/m2 on day 1, 5-FU 600 mg/m2/day for 120 hours)
Number of subjects: 27
Study 8897078 — intervention group
Group type: EXPERIMENTAL
Intervention: 95 mg metoprolol and 40 mg pantoprazole (test)
Number of subjects: 18
Study 8897078 — intervention group
Group type: COMPARATOR
Intervention: 95 mg metoprolol and placebo (reference)
Number of subjects: 18
Study 1796419 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclate
Number of subjects: 23
Study 1796419 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemofil-M
Number of subjects: 23
Study 6391981 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting alone
Number of subjects: 88
Study 6391981 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric suction
Number of subjects: 88
Study 6391981 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting plus cimetidine
Number of subjects: 88
Study 31434775 — intervention group
Group type: EXPERIMENTAL
Intervention: German Unidimensional Self‐Efficacy Scale for Multiple Sclerosis (USE‐MS-G)
Number of subjects: 322
Study 29609017 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium-containing gummies
Number of subjects: 44
Study 29609017 — intervention group
Group type: COMPARATOR
Intervention: No gummies
Number of subjects: 44
Study 29609017 — intervention group
Group type: COMPARATOR
Intervention: Calcium-containing gummies and No gummies
Number of subjects: 44
Study 26077874 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (500 mg) with iron tablet
Number of subjects: 76
Study 26077874 — intervention group
Group type: COMPARATOR
Intervention: Placebo with iron tablet
Number of subjects: 76
Study 25375279 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Exercise (CE: 45 minutes at 65‐70% of heart rate reserve)
Number of subjects: 16
Study 25375279 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval Exercise (IE: 5 x 3 minute intervals at 80‐85% HRR with two minutes of active recovery at 65‐70% HRR)
Number of subjects: 16
Study 22050051 — intervention group
Group type: EXPERIMENTAL
Intervention: DU-125530
Number of subjects: 50
Study 22050051 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 50
Study 20505197 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior lamellar tarsal rotation surgery
Number of subjects: 356
Study 17607430 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivoxel spectroscopy with short echo time (TE)
Number of subjects: 31
Study 17607430 — intervention group
Group type: COMPARATOR
Intervention: Normal cerebral parenchyma
Number of subjects: 31
Study 16109986 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-implant overdentures (IOD)
Number of subjects: 60
Study 16109986 — intervention group
Group type: COMPARATOR
Intervention: Conventional dentures (CD)
Number of subjects: 60
Study 12615557 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic filter placement
Number of subjects: 400
Study 10709119 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO 400 units/kg every alternate day for 10 doses
Number of subjects: 42
Study 10709119 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 42
Study 10709119 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO
Number of subjects: 42
Study 7745512 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal)
Number of subjects: 89
Study 7745512 — intervention group
Group type: COMPARATOR
Intervention: Air placebo
Number of subjects: 89
Study 2183056 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) 100 mg per day
Number of subjects: 52
Study 2183056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 7403018 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiannual individual advice and health education campaign
Number of subjects: 19390
Study 7403018 — intervention group
Group type: COMPARATOR
Intervention: Control group (baseline examination)
Number of subjects: 19390
Study 7403018 — intervention group
Group type: EXPERIMENTAL
Intervention: Random sample of intervention group
Number of subjects: 19390
Study 7403018 — intervention group
Group type: COMPARATOR
Intervention: Random sample of control group
Number of subjects: 19390
Study 7403018 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk subjects of intervention group
Number of subjects: 19390
Study 7403018 — intervention group
Group type: COMPARATOR
Intervention: High-risk subjects of control group
Number of subjects: 19390
Study 31425453 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (LPPLC, 7 mm Hg)
Number of subjects: 82
Study 31425453 — intervention group
Group type: COMPARATOR
Intervention: Normal pressure pneumoperitoneum (NPPLC, 14 mm Hg)
Number of subjects: 82